Zacks.com on MSN11h
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
Moderna (MRNA) closed at $58.39 in the latest trading session, marking a -0.56% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.97%. Elsewhere, the Dow saw an ...
Flu shots, vaccines available at clinic this Friday
GAYLORD — The Otsego County Commission on Aging (OCCOA) Healthy Aging Program is partnering with the Health Department of ...
Artnet17h
An Artist Invents a ‘Rediscovered’ Woman Painter. Is It a Bold Critique of the Art World or Just Another Gimmick?
Gabriel Sierra’s creation of fictional artist Lucy Otter raises questions about privilege and the commodification of gender.
Pfizer and BioNTech win Covid vaccine court battle to have jab patents from rival firm revoked
The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life ...
How the rapid development of COVID vaccines prepares us for future pandemics
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
Which COVID Vaccine Is Better? Infectious Disease Doctors Explain
The Centers for Disease Control and Prevention (CDC) currently recommends that everyone aged 6 months and up get the Moderna or Pfizer COVID-19 vaccines. The Novavax vaccine is authorized by the U.S.